Medtronic Defibrillator Lead Recall Attorneys
Medtronic Study to Compare Stent vs. Abbott's
- E-mail this Article
- Print this Article
- Text Size: A A
Editor: Marc Jay Bern
Profession: Defective Medical Device Lawyer
Category: Medtronic Lawsuit News
Medtronic, medical device maker, is working on a global study that will compare the company's Endeavor drug-eluting stent to Abbott Laboratory's competing Xience V drug-eluting stent.
The first round of patients were implanted with the device two weeks ago, in Europe. The trial, called RESOLUTE III study, will include a total of 2,300 patients.
The Endeavor stent won European regulatory approval in October and U.S. approval in January. Stents are tiny, mesh-wire tubes that prop open arteries after they have been surgically cleared of fatty plaque.
Trackback Pings
TrackBack URL for this entry:
http://myblog.clarislaw.com/usa/mt-tb.cgi/2409
